SELVAS Healthcare, Inc.
Financials
Valuation Metrics
SELVAS Healthcare, Inc.'s Market Cap is ₩555B. At end of 2025 it was ₩1496B. Ranked #1646 of 2,410 in KR market (top 68%), #981 of 1,631 on KOSDAQ (top 60%), #64 of 94 in Health Care Equipment & Services (top 68%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 55.47B KRW | KR#1,646/2,410 Sec#64/94 |
| Revenue | 31.69B KRW | KR#2,007/2,410 Sec#64/94 |
| Net Income | 8.70B KRW | KR#1,018/2,410 Sec#28/94 |
| Total Assets | 85.20B KRW | KR#1,898/2,410 Sec#60/94 |
| Net Assets | 75.79B KRW | KR#1,622/2,410 Sec#48/94 |
| Employees | 132 | KR#1,424/2,410 Sec#49/94 |
| Value | ||
| P/E | 6.38x | KR#557/2,410 Sec#13/94 |
| P/B | 0.73x | KR#1,238/2,410 Sec#27/94 |
| PEG | 0.02x | KR#189/2,410 Sec#7/94 |
| P/S | 1.75x | KR#1,779/2,410 Sec#49/94 |
| EV/EBITDA | 34.93x | KR#1,270/2,410 Sec#41/94 |
| FCF Yield | -1.00% | KR—/2,410 Sec—/94 |
| Profitability | ||
| ROE | 11.48% | KR#510/2,410 Sec#21/94 |
| ROA | 10.21% | KR#264/2,410 Sec#13/94 |
| Op. Margin | 4.92% | KR#970/2,410 Sec#40/94 |
| Revenue Growth | 0.04% | KR#1,523/2,410 Sec#73/94 |
| Earnings Growth | 328.64% | KR#155/2,410 Sec#8/94 |
| Financial Health | ||
| Debt Ratio | 12.42% | KR#194/2,410 Sec#12/94 |
| Total Debt | 1.96B KRW | KR#1,905/2,410 Sec#69/94 |
| FCF | -552.0M KRW | KR#1,255/2,410 Sec#37/94 |
| Cash | 2.95B KRW | KR#2,165/2,410 Sec#87/94 |
| Current Ratio | 7.45x | KR#162/2,410 Sec#15/94 |
| Net Debt/EBITDA | -0.63x | KR#459/2,410 Sec#17/94 |
| Performance | ||
| 1Y Return | -37.81% | KR#1,654/2,410 Sec#57/94 |
| 1M Return | -18.98% | KR#2,119/2,410 Sec#90/94 |
| From 52W High | -71.23% | KR#2,096/2,410 Sec#80/94 |
| 1Y MDD | -68.27% | KR#1,884/2,410 Sec#69/94 |
| Trading | ||
| Volume | 79,819 shares | KR#714/2,410 Sec#28/94 |
| Trading Value | 168.5M KRW | KR#1,210/2,410 Sec#49/94 |
| Foreign Own. | 4.17% | KR#1,006/2,410 Sec#32/94 |
| Per Share | ||
| EPS | 338 KRW | KR#1,123/2,410 Sec#33/94 |
| BPS | 2,944 KRW | KR#1,883/2,410 Sec#60/94 |
Company Info
Selvas Healthcare was established in 1999 to develop and sell medical diagnostic devices and visual assistive technology devices, enhancing its technological capabilities through a 2015 merger with Jawon Medical. The company operates two divisions: Accuniq, for body composition analyzers and automatic blood pressure monitors, and Himss, which produces braille information terminals and reading magnifiers for the visually impaired. Leveraging 30 years of technological expertise, Selvas Healthcare is growing as a specialized digital healthcare company, expanding into international markets via partnerships with fitness distribution channels. Selvas Healthcare was established in 2014 and is headquartered in Yuseong-gu, Daejeon.